The rise of Viagra initially drove a surge for pharma, however recent developments present a uncertain picture for those considering a stake. Off-patent competitors are eroding revenue, and ongoing legal battles add https://shaniaurvy102780.post-blogs.com/62031958/the-blue-pill-and-big-pharma-a-precarious-investment